HYPERSENSITIVITY PNEUMONITIS
Clinical trials for HYPERSENSITIVITY PNEUMONITIS explained in plain language.
Never miss a new study
Get alerted when new HYPERSENSITIVITY PNEUMONITIS trials appear
Sign up with your email to follow new studies for HYPERSENSITIVITY PNEUMONITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled therapy aims to slow lung scarring
Disease control Recruiting nowThis study tests an inhaled version of the drug pirfenidone (AP01) in 375 adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. Participants receive either a high dose, low dose, or placebo twice daily for 52 weeks, alongside their usual c…
Matched conditions: HYPERSENSITIVITY PNEUMONITIS
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Could weak legs be making you breathless? new study investigates
Knowledge-focused Recruiting nowThis study looks at why people with interstitial lung disease (ILD) often feel short of breath and have trouble exercising. Researchers think leg muscle problems might be a cause. They will measure leg muscle strength and structure in 40 adults with ILD, and test whether extra ox…
Matched conditions: HYPERSENSITIVITY PNEUMONITIS
Phase: NA • Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated May 17, 2026 01:50 UTC
-
New biobank aims to unlock secrets of rare lung diseases
Knowledge-focused Recruiting nowThis study is creating a registry and biobank for people with interstitial lung disease (ILD), including sarcoidosis, pulmonary fibrosis, and hypersensitivity pneumonitis. Researchers will collect medical data and biological samples from up to 1,000 participants to better underst…
Matched conditions: HYPERSENSITIVITY PNEUMONITIS
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC